Anna Melissa Schlitter
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 40
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 13
- Biophysics top 2%
- Surgery top 5%
- Pancreatitis Pathology and Treatment 10
- Cholangiocarcinoma and Gallbladder Cancer Studies 7
- Pediatric Hepatobiliary Diseases and Treatments 4
- Epidemiology top 5%
- Neuroendocrine Tumor Research Advances 18
-
- Renal cell carcinoma treatment 6
-
- Neuroblastoma Research and Treatments 4
- Co-authors
- Iréne EspositoKatja SteigerGünter KlöppelBjörn KonukiewitzWilko WeichertTingying PengNassir NavabAmit Sethi
- Cited by
- OncologyCancer ResearchBiophysics
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (2 papers)PLoS ONE (1 paper)
- Partner nations
- GermanyUnited KingdomTürkiye
In The Last Decade
Anna Melissa Schlitter
76 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Oncology 1.4k
- Cancer Research 585
- Biophysics 115
- Surgery 877
- Epidemiology 641
Countries citing papers authored by Anna Melissa Schlitter
This map shows the geographic impact of Anna Melissa Schlitter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Melissa Schlitter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Melissa Schlitter more than expected).
Fields of papers citing papers by Anna Melissa Schlitter
This network shows the impact of papers produced by Anna Melissa Schlitter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Melissa Schlitter. The network helps show where Anna Melissa Schlitter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anna Melissa Schlitter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2022 | 17 | |
| 3 | 2021 | 33 | |
| 4 | 2021 | 8 | |
| 5 | 2021 | 22 | |
| 6 | 2021 | 3 | |
| 7 | 2021 | 29 | |
| 8 | 2020 | 5 | |
| 9 | 2018 | 81 | |
| 10 | 2017 | 61 | |
| 11 | 2017 | 51 | |
| 12 | 2017 | 148 | |
| 13 | 2015 | 24 | |
| 14 | 2015 | 8 | |
| 15 | 2015 | 19 | |
| 16 | 2015 | 70 | |
| 17 | 2014 | 9 | |
| 18 | 2014 | 65 | |
| 19 | 2012 | 69 | |
| 20 | 2007 | 56 |
About Anna Melissa Schlitter
Anna Melissa Schlitter is a scholar working on Oncology, Cancer Research and Hepatology, having authored 77 papers that have together received 3.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (40 papers), Neuroendocrine Tumor Research Advances (18 papers), Cancer Genomics and Diagnostics (13 papers), Pancreatitis Pathology and Treatment (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Renal cell carcinoma treatment (6 papers), Pediatric Hepatobiliary Diseases and Treatments (4 papers) and Neuroblastoma Research and Treatments (4 papers). The work is most often cited by research in Oncology (1.4k citations), Cancer Research (585 citations) and Biophysics (115 citations). Anna Melissa Schlitter has collaborated with scholars based in Germany, United Kingdom and Türkiye. Frequent co-authors include Iréne Esposito, Katja Steiger, Günter Klöppel, Björn Konukiewitz, Wilko Weichert, Tingying Peng, Nassir Navab, Amit Sethi, Maximilian Baust and Abhishek Vahadane. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.